Clinical Trial Update: A Study of CD19 UCAR-T Cells in Subjects With Autoimmune Diseases [NA]

View source ↗

Summary

A clinical trial update evaluating CD19 UCAR-T cell therapy in autoimmune diseases; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anca-associated Vasculitis
• Antiphospholipid Syndrome
• Idiopathic Inflammatory Myopathies
• Immune Thrombocytopenia
• Sjögren Syndrome
• Systemic Lupus Erythematosus
• Systemic Sclerosis

Drugs mentioned

• CD19 UCAR T Cells

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Systemic Lupus Erythematosus, Idiopahic Inflammatory Myopathies | NA | Status: NOT_YET_RECRUITING